What is Corvus Pharmaceuticals's capex?

Corvus Pharmaceuticals (CRVS) reported capex of $91K in Q1 2026.

How has Corvus Pharmaceuticals's capex changed year-over-year?

Corvus Pharmaceuticals's capex increased by 152.8% year-over-year, from $36K to $91K.

What does capex mean?

Cash spent on property, plant, and equipment — the primary measure of investment in productive capacity and infrastructure.

Corvus Pharmaceuticals CRVS CapEx

CapEx at other companies

Eli LillyLLY

$2.33B+54.0%

Regeneron PharmaceuticalsREGN

$230.6M+0.6%

AbbVieABBV

$265M+12.8%

Cullinan Therapeutics, Inc.CGEM

$11K—

Arcus BiosciencesRCUS

$0-100%

Nektar TherapeuticsNKTR

$18K+800%

Other financials

Income statement

See full

Operating income-$14.9M-49.9%

Net income-$13.7M-190%

EPS (diluted)-$0.15-15.4%

Balance sheet

See full

Cash & equivalents$40.1M+702%

Total debt$834.0K-27.7%

Total equity$240.7M+388%

Total assets$253.2M+326%

Cash flow

See full

Operating cash flow-$10.4M-25.5%

Free cash flow-$10.5M-26.1%

Valuation

See full

Market cap$1.09B+259%

Enterprise value$1.05B+251%

Returns & leverage

See full

Return on equity-30.5%-12.5pp

Debt / equity0×0.0×

Current ratio19.8×+14.9×

Where this comes from

Reported directly by Corvus Pharmaceuticals in its filing.

Tagged under the XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment.

The official record: Corvus Pharmaceuticals’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Corvus Pharmaceuticals's capex.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Corvus Pharmaceuticals's capex?: Corvus Pharmaceuticals (CRVS) reported capex of $91K in Q1 2026.
How has Corvus Pharmaceuticals's capex changed year-over-year?: Corvus Pharmaceuticals's capex increased by 152.8% year-over-year, from $36K to $91K.
What does capex mean?: Cash spent on property, plant, and equipment — the primary measure of investment in productive capacity and infrastructure.